Online citations, reference lists, and bibliographies.
← Back to Search

Impact Of Age On Long-Term Outcomes Of Surgery For Malignant Pleural Mesothelioma.

C. Yang, Brandon W Yan, R. Meyerhoff, Shakir M Saud, B. Gulack, P. Speicher, M. Hartwig, T. D’amico, D. Harpole, M. Berry
Published 2016 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
BACKGROUND Although malignant pleural mesothelioma (MPM) is generally a disease associated with more advanced age, the association of age, treatment, and outcomes has not been well-characterized. We evaluated the impact of age on outcomes in patients with MPM to provide data for use in the treatment selection process for elderly patients with potentially resectable disease. PATIENTS AND METHODS Overall survival (OS) of patients younger than 70 and 70 years or older with Stage I to III MPM who underwent cancer-directed surgery or nonoperative management in the Surveillance, Epidemiology, and End Results database (2004-2010) was evaluated using multivariable Cox proportional hazard models and propensity score-matched analysis. RESULTS Cancer-directed surgery was used in 284 of 879 (32%) patients who met inclusion criteria, and was associated with improved OS in multivariable analysis (hazard ratio, 0.71; P = .001). Cancer-directed surgery was used much less commonly in patients 70 years and older compared with patients younger than 70 years (22% [109/497] vs. 46% [175/382]; P < .001), but patients 70 years and older had improved 1-year (59.4% vs. 37.9%) and 3-year (15.4% vs. 8.0%) OS compared with nonoperative management. The benefit of surgery in patients 70 years and older was observed even after propensity score-matched analysis was used to control for selection bias. CONCLUSION Surgical treatment is associated with improved survival compared with nonoperative management for both patients younger than 70 years and patients aged 70 years or older.
This paper references
Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database
V. Rusch (2012)
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
W. Weder (2007)
Survival in the elderly after pneumonectomy for early-stage non-small cell lung cancer: a comparison with nonoperative management.
P. Speicher (2014)
[Malignant pleural mesothelioma].
Q. Kong (1983)
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)
Extrapleural pneumonectomy for malignant mesothelioma: an Italian multicenter retrospective study.
L. Spaggiari (2014)
Pleural malignant mesothelioma epidemic: Incidence, modalities of asbestos exposure and occupations involved from the Italian National Register
A. Marinaccio (2012)
Surgical therapy of mesothelioma.
D. Rice (2011)
Malignant pleural mesothelioma: surgical management in 285 patients.
P. Schipper (2008)
Frequency of Use and Predictors of Cancer-Directed Surgery in the Management of Malignant Pleural Mesothelioma in a Community-Based (Surveillance, Epidemiology, and End Results [SEER]) Population
R. Flores (2010)
Malignant Pleural Mesothelioma: A Population-Based Study of Survival
M. Milano (2010)
Future trends of mesothelioma mortality in Japan based on a risk function.
Tomoya Myojin (2012)
Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey
G. Ceresoli (2014)
Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality.
B. Burt (2014)
Pleural resection and pleural infusion chemotherapy for therapy of malignant pleural mesothelioma.
J. Zhang (2014)
AJCC Cancer Staging Manual
M. B. Amin (2002)
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
N. Vogelzang (2003)
Projected mesothelioma incidence in men in New South Wales
M. Clements (2007)
The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050
J. Hodgson (2005)
Multimodality approach in management of malignant pleural mesothelioma.
S. Neragi-Miandoab (2006)
Extrapleural pneumonectomy after induction chemotherapy: perioperative outcome in 251 mesothelioma patients from three high-volume institutions.
O. Lauk (2014)
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
R. Flores (2008)
Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.
R. Meyerhoff (2015)
Prognostic factors in diffuse malignant pleural mesothelioma. A study of 167 patients.
E. Chailleux (1988)
Time trend of mesothelioma incidence in the United States and projection of future cases: An update based on SEER data for 1973 through 2005
B. Price (2009)
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.
P. Ruffié (1989)
Surgical assessment of malignant pleural mesothelioma: have we reached a critical stage?
A. Nakas (2010)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar